LISATA THERAPEUTICS, INC. Preferred Stock Dividends and Other Adjustments
LISATA THERAPEUTICS, INC. (LSTA) reported Preferred Stock Dividends and Other Adjustments of $0 for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:PreferredStockDividendsAndOtherAdjustments · last filed 2014-03-13
- LISATA THERAPEUTICS, INC. preferred stock dividends and other adjustments for the quarter ending 2013-12-31 was $0.00, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. preferred stock dividends and other adjustments for the quarter ending 2013-09-30 was $0.00, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. preferred stock dividends and other adjustments for the quarter ending 2013-06-30 was $0.00, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. preferred stock dividends and other adjustments for the quarter ending 2013-03-31 was $0.00, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. preferred stock dividends and other adjustments for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- LISATA THERAPEUTICS, INC. preferred stock dividends and other adjustments for fiscal 2012 was $528.02K, a 17.47% decline from fiscal 2011.
- LISATA THERAPEUTICS, INC. preferred stock dividends and other adjustments for fiscal 2011 was $639.76K.
| Period end | Preferred Stock Dividends and Other Adjustments 3 month | Preferred Stock Dividends and Other Adjustments 6 month | Preferred Stock Dividends and Other Adjustments 9 month | Preferred Stock Dividends and Other Adjustments 12 month |
|---|---|---|---|---|
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $0.00 derived: sum of 2 quarters · filed 2014-03-13 | $0.00 derived: sum of 3 quarters · filed 2014-03-13 | $0.00 10-K · filed 2014-03-13 |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-07 | $0.00 derived: sum of 2 quarters · filed 2013-11-07 | $0.00 10-Q · filed 2013-11-07 | $264.59K derived: sum of 4 quarters · filed 2014-03-13 |
| 2013-06-30 | $0.00 10-Q · filed 2013-08-08 | $0.00 10-Q · filed 2013-08-08 | $264.59K derived: sum of 3 quarters · filed 2014-03-13 | $331.79K derived: sum of 4 quarters · filed 2014-03-13 |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-09 | $264.59K derived: sum of 2 quarters · filed 2014-03-13 | $331.79K derived: sum of 3 quarters · filed 2014-03-13 | $420.18K derived: sum of 4 quarters · filed 2014-03-13 |
| 2012-12-31 | $264.59K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $331.79K derived: sum of 2 quarters · filed 2014-03-13 | $420.18K derived: sum of 3 quarters · filed 2014-03-13 | $528.02K 10-K · filed 2014-03-13 |
| 2012-09-30 | $67.20K 10-Q · filed 2013-11-07 | $155.59K derived: sum of 2 quarters · filed 2013-11-07 | $263.43K 10-Q · filed 2013-11-07 | $395.13K derived: sum of 4 quarters · filed 2013-11-07 |
| 2012-06-30 | $88.39K 10-Q · filed 2013-08-08 | $196.24K 10-Q · filed 2013-08-08 | $327.93K derived: sum of 3 quarters · filed 2013-08-08 | $478.58K derived: sum of 4 quarters · filed 2013-08-08 |
| 2012-03-31 | $107.84K 10-Q · filed 2013-05-09 | $239.54K derived: sum of 2 quarters · filed 2013-05-09 | $390.19K derived: sum of 3 quarters · filed 2013-05-09 | $560.98K derived: sum of 4 quarters · filed 2013-05-09 |
| 2011-12-31 | $131.69K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | $282.35K derived: sum of 2 quarters · filed 2013-03-11 | $453.13K derived: sum of 3 quarters · filed 2013-03-11 | $639.76K 10-K · filed 2013-03-11 |
| 2011-09-30 | $150.66K 10-Q · filed 2012-11-13 | $321.44K derived: sum of 2 quarters · filed 2012-11-13 | $508.07K 10-Q · filed 2012-11-13 | |
| 2011-06-30 | $170.78K 10-Q · filed 2012-08-14 | $357.42K 10-Q · filed 2012-08-14 | ||
| 2010-12-31 | $237.96K 8-K · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |